Opendata, web and dolomites
H2020 projects about "immunotherapies"
The page lists 65 projects related to the topic "immunotherapies".
| # | |||
|---|---|---|---|
| 1 | APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy | 2015 |
| 2 | Tolltum | Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment | 2015 |
| 3 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
| 4 | REGiREG | Regulating the immune regulators: targeting adaptive immune control | 2015 |
| 5 | TARG-SUP | Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells. | 2016 |
| 6 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 7 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 8 | HONEYDIAB-8 | Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes | 2016 |
| 9 | GLUTORHIV | Glucose metabolism and mTOR pathway role in CD8+ T cell control of HIV-1 | 2016 |
| 10 | FIBROCAN | Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells | 2016 |
| 11 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 12 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 13 | STRUGGLE | Statistical physics of immune-viral co-evolution | 2017 |
| 14 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
| 15 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 16 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
| 17 | BioNanoPattern | Protein nano-patterning using DNA nanotechnology; control of surface-based immune system activation | 2018 |
| 18 | CombaTCancer | Rational combination therapies for metastatic cancer | 2018 |
| 19 | SymPAtHY | A neurosplenic pathway coupling Immunity and Hypertension | 2017 |
| 20 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
| 21 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 22 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
| 23 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 24 | TCELLTIGIT | Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy | 2019 |
| 25 | KILNEV | Killing Senescent Cells as a Novel Method to Eliminate Nevi | 2018 |
| 26 | GDCOLCA | Understanding gamma delta T cells in colon cancer metastasis | 2018 |
| 27 | DCPOIESIS | Steady-state and demand-driven dendritic cell generation | 2018 |
| 28 | RV001 | RV001: An anti-metastatic cancer vaccine | 2018 |
| 29 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
| 30 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 31 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 32 | SkinTrmDeep | Tissue Resident Memory (Trm) CD8+ T cells: Genome-wide dissection of cellular differentiation and heterogeneity | 2019 |
| 33 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 34 | MitoGuide | Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment | 2019 |
| 35 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 36 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 37 | 3DLT | 3D Living Tissues | 2019 |
| 38 | ImmunoBioSynth | Synergistic engineering of anti-tumor immunity by synthetic biomaterials | 2019 |
| 39 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 40 | TRACERxTME | Constructing an evolutionary atlas of the immune landscape in lung cancer | 2019 |
| 41 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 42 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 43 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 44 | IBL-302 | Inflection Bioscience unique dual mechanism, small molecule, orally available therapeutic targeting major unmet medical needs in breast cancer | 2019 |
| 45 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 46 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 47 | AmInnovation | Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy. | 2019 |
| 48 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
| 49 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 50 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 51 | ARTimmune | Programmable ARTificial immune systems to fight cancer | 2019 |
| 52 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 53 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 54 | PeptiCHIP | PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy | 2019 |
| 55 | RV001 | RV001: An anti-metastatic cancer vaccine | 2019 |
| 56 | Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies | 2019 |
| 57 | TrojanDC | TrojanDC | 2019 |
| 58 | Synthetic T-rEX | A synthetic biology approach for T cell exhaustion | 2020 |
| 59 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 60 | MISTRAL | Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination | 2020 |
| 61 | ImmunoSep | Personalized immunotherapy in sepsis: a precision medicine based approach | 2020 |
| 62 | NATURE-ETN | Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification | 2020 |
| 63 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 64 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 65 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |